Francesca Valcamonico

Author

Also Known As

F Valcamonico, F. Valcamonico, F., Valcamonico, FRANCESCA VALCAMONICO, Francesca Valcamonico, Valcamonico, F., Valcamonico, Francesca

Publications

484

Citations

H-Index

Concepts

All Affiliations

University of Brescia Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia University of Verona Azienda Ospedaliera Universitaria Integrata Verona Tecnologie Avanzate (Italy)

About

Francesca Valcamonico is an author at University of Brescia specializing in oncology, medicine, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	196
2	Health Sciences	1	1	17
3	Cell Biology	1	1	13
4	Hepatology	1	1	17
5	Neurology	1	1	40

Francesca Valcamonico

Publications

337

Citations

H-Index

Page 1

	Year	Citations
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial Vittorio Ferrari, Francesca Valcamonico, Vito Amoroso, Cancer Chemotherapy and Pharmacology OncologyPhase Ii TrialGastrointestinal OncologyPancreatic CancerMedicine	2005	79
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients Chiara Foroni, Nataša Zarovni, Laura Bianciardi, Biomedicines	2020	43
Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma Francesca Valcamonico, Vittorio Ferrari, Vito Amoroso, Journal of Neuro-Oncology Neuro-oncologyUrologyGenitourinary CancerMedicineNeurology	2008	40
Osteoblastic flare in a patient with advanced gastric cancer after treatment with pemetrexed and oxaliplatin: implications for response assessment with RECIST criteria Vito Amoroso, Frida Pittiani, Salvatore Grisanti, BMC Cancer	2007	19
Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey Alberto Diminutto, Umberto Basso, Marco Maruzzo, Clinical Genitourinary Cancer Surgical OncologyMedicineRetrospective Multicenter SurveyPathologyImmune Checkpoint Inhibitor	2015	18
Idiopathic intracranial hypertension: A possible complication in the natural history of advanced prostate cancer Francesca Valcamonico, Giuseppina Arcangeli, Francesca Consoli, International Journal of Urology	2013	17
Deep electro-hyperthermia (EHY) with or without thermo-active agents in patients with advanced hepatic cell carcinoma: Phase II study Vittorio Ferrari, Serena Ponti, Francesca Valcamonico, Journal of Clinical Oncology Surgical OncologyPhase Ii StudyThermal TherapyDeep Electro-hyperthermiaThermo-active Agents	2007	17
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial Orazio Caffo, Cinzia Ortega, Franco Nolè, European Journal of Cancer UrologyMedicinePharmacologyClinical TrialsFirst-line Treatment	2021	17
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity Francesca Bedussi, Diego Galli, Martina Fragni, Pharmacology	2017	16
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib Elisa Rossini, Valentina Bosatta, Andrea Abate, Clinical Genitourinary Cancer Tumor BiologyCdk4/6 Inhibitor PalbociclibOncologyMedicineCisplatin Cytotoxicity	2021	13

Page 1